Nanoplatform-based strategies for enhancing the lethality of current antitumor PDT

Xin-Xin Lu1, Chun Xue1, Jian-Hui Dong1

  • 1Institute of Advanced Materials and Flexible Electronics (IAMFE), School of Chemistry and Materials Science, Nanjing University of Information Science & Technology, Nanjing, 210044, China. gaofan@nuist.edu.cn.

PubMed

Insights

Photodynamic therapy (PDT) shows promise in cancer treatment but faces challenges like tumor hypoxia. This review explores nanoplatform strategies to enhance PDT

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Photochemistry

Background:

  • Photodynamic therapy (PDT) offers controllable and safe cancer treatment.
  • Tumor hypoxia, poor light penetration, and tumor defenses limit PDT efficacy.
  • Enhancing PDT's tumor-killing power is crucial for clinical application.

Purpose of the Study:

  • To review nanoplatform-based strategies for amplifying photodynamic therapy's (PDT) tumoricidal capability.
  • To discuss current limitations and future prospects of nanoplatform-enhanced PDT.

Main Methods:

  • Literature review of nanoplatform-involved strategies for PDT sensitization.
  • Analysis of factors hindering PDT efficacy and proposed solutions.
  • Discussion of bottlenecks and future directions in nanomedicine for PDT.

Main Results:

  • Nanoplatforms can significantly enhance the antitumor effects of PDT.
  • Various strategies exist to overcome PDT limitations using nanotechnology.
  • Key challenges remain in optimizing nanoplatform design and delivery for maximum efficacy.

Conclusions:

  • Nanoplatforms are vital for improving photodynamic therapy (PDT) efficacy in oncology.
  • Further research into nanoplatform design is needed to overcome existing bottlenecks.
  • Optimized nanoplatform-based PDT holds significant promise for future cancer treatment.